0 Commentaires
0 Parts
1K Vue
0 Avis
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Cours
-
Connectez-vous pour aimer, partager et commenter!
-
Pharmaceutical Contract Manufacturing Market Insights for Pharma CompaniesThe global Pharmaceutical Contract Manufacturing Market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, registering a CAGR of 10.4% from 2026 to 2033. North America accounted for the largest market share of 38.44% in 2025, supported by a mature pharmaceutical ecosystem, robust R&D investments, and...0 Commentaires 0 Parts 38 Vue 0 Avis
-
Blow Fill Seal (BFS) Technology Market: Transforming Sterile Pharmaceutical Packaging Through Advanced Aseptic ManufacturingThe Global Blow Fill Seal (BFS) Technology Market is witnessing accelerated expansion as pharmaceutical manufacturers increasingly prioritize sterile, contamination-free, and high-efficiency packaging systems. Blow-fill-seal technology has evolved into one of the most reliable aseptic packaging methods for liquid pharmaceuticals, biologics, ophthalmic solutions, respiratory drugs, vaccines, and...0 Commentaires 0 Parts 1K Vue 0 Avis
-
Europe Blow-Fill-Seal BFS Products Market Forecast Reaches USD 4.37 BillionAccording to a new report from Intel Market Research, the Europe BFS (Blow‑Fill‑Seal) Products market was valued at USD 2.01 billion in 2024 and is projected to grow from USD 2.24 billion in 2025 to USD 4.37 billion by 2032, exhibiting a robust CAGR of 11.5% during the forecast period (2025–2032). This expansion is driven by the continent’s mature pharmaceutical ecosystem, stringent...0 Commentaires 0 Parts 912 Vue 0 Avis
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Commentaires 0 Parts 538 Vue 0 Avis